A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent

Padmanee Sharma; Marc-Oliver Grimm; Matthew D Galsky; Ari Baron; Sergio Bracarda; Arlene Siefker-Radtke; Alexandre Lambert; Alex Azrilevich; Margitta Retz

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent

【24h】

A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent

机译：铂类药物治疗后进展的转移性或不可切除的尿路上皮癌患者的II期单臂研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2015年第s2期|共页
作者
Padmanee Sharma; Marc-Oliver Grimm; Matthew D Galsky; Ari Baron; Sergio Bracarda; Arlene Siefker-Radtke; Alexandre Lambert; Alex Azrilevich; Margitta Retz;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma who have Progressed Following Treatment with Platinum-based Chemotherapy: A Single-arm, Multicenter, Phase 2 Trial [J] . Bochner Bernard H. European urology . 2017,第2期

机译：Re：atezolizumab患者局部晚期和转移性尿路上皮癌的患者进行后续处理铂化疗治疗：单臂，多中心，第2期试验
2. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial [J] . Rosenberg Jonathan E., Hoffman-Censits Jean, Powles Tom, The Lancet . 2016,第10031期

机译：atezolizumab患者患有铂化疗治疗后的局部晚期和转移性尿路上皮癌：单臂，多期，第2期试验
3. Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed following Treatment with Platinum-Based Chemotherapy: A Single-Arm, Multicentre, Phase 2 Trial [J] . Chang Sam S. The Journal of Urology . 2016,第6期

机译：回复：Atezolizumab在铂类化疗治疗后进展为局部晚期转移性尿路上皮癌的患者中：单臂，多中心，2期试验
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Investigating Molecular Targets of Phosphaplatins: A Class of Novel Non-DNA-Binding Platinum Anticancer Agents in the Treatment of Ovarian Cancer. [D] . Majmudar, Pooja M. 2011

机译：研究磷铂的分子靶标：一类在卵巢癌治疗中的新型非DNA结合铂抗癌药。
6. A Phase II single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent [O] . Padmanee Sharma, Marc-Oliver Grimm, Matthew D Galsky, 2015

机译：铂类药物治疗后进展的转移性或无法切除的尿路上皮癌患者的II期单臂研究
7. A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent [O] . Padmanee Sharma, Marc-Oliver Grimm, Matthew D Galsky, 2015

机译：铂类药物治疗后进展的转移性或无法切除的尿路上皮癌患者的II期单臂研究

A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent

著录项

相似文献

相关主题

期刊订阅